A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer
- 1 May 1991
- Vol. 67 (9) , 2253-2257
- https://doi.org/10.1002/1097-0142(19910501)67:9<2253::aid-cncr2820670907>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Adjuvant chemotherapy in head and neck cancerBritish Journal of Cancer, 1990
- Leucovorin rescue revisited.Journal of Clinical Oncology, 1990
- Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.Journal of Clinical Oncology, 1988
- Overcoming methotrexate resistance by a lipophilic antifolate (BW 301U): from theory to models to practiceAdvances in Enzyme Regulation, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- Changing role of chemotherapy in treatment of head and neck cancerThe American Journal of Medicine, 1982
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981
- Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.BMJ, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958